These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19363487)

  • 1. Telomere recombination requires the MUS81 endonuclease.
    Zeng S; Xiang T; Pandita TK; Gonzalez-Suarez I; Gonzalo S; Harris CC; Yang Q
    Nat Cell Biol; 2009 May; 11(5):616-23. PubMed ID: 19363487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MUS81 endonuclease is essential for telomerase negative cell proliferation.
    Zeng S; Yang Q
    Cell Cycle; 2009 Jul; 8(14):2157-60. PubMed ID: 19617716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.
    Jiang WQ; Zhong ZH; Henson JD; Reddel RR
    Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saccharomyces cerevisiae Mus81-Mms4 prevents accelerated senescence in telomerase-deficient cells.
    Schwartz EK; Hung SH; Meyer D; Piazza A; Yan K; Fu BXH; Heyer WD
    PLoS Genet; 2020 May; 16(5):e1008816. PubMed ID: 32469862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere maintenance by telomerase and by recombination can coexist in human cells.
    Cerone MA; Londono-Vallejo JA; Bacchetti S
    Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
    Grobelny JV; Kulp-McEliece M; Broccoli D
    Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.
    Draskovic I; Arnoult N; Steiner V; Bacchetti S; Lomonte P; Londoño-Vallejo A
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15726-31. PubMed ID: 19717459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.
    Osterwald S; Deeg KI; Chung I; Parisotto D; Wörz S; Rohr K; Erfle H; Rippe K
    J Cell Sci; 2015 May; 128(10):1887-900. PubMed ID: 25908860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
    Potts PR; Yu H
    Nat Struct Mol Biol; 2007 Jul; 14(7):581-90. PubMed ID: 17589526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hRad21 overexpresses and localizes to the ALT-associated promyelocytic leukemia body in ALT cells.
    Zhao B; Wang ZJ; Yi BQ; Ma HC; Xu HM
    Cancer Biol Ther; 2010 Jun; 9(12):978-83. PubMed ID: 20364118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear receptors regulate alternative lengthening of telomeres through a novel noncanonical FANCD2 pathway.
    Xu M; Qin J; Wang L; Lee HJ; Kao CY; Liu D; Songyang Z; Chen J; Tsai MJ; Tsai SY
    Sci Adv; 2019 Oct; 5(10):eaax6366. PubMed ID: 31633027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination.
    Celli GB; Denchi EL; de Lange T
    Nat Cell Biol; 2006 Aug; 8(8):885-90. PubMed ID: 16845382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
    Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
    Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUS81-EME2 promotes replication fork restart.
    Pepe A; West SC
    Cell Rep; 2014 May; 7(4):1048-55. PubMed ID: 24813886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular evidence for the alternative lengthening of telomeres (ALT) mechanism in chicken.
    O'Hare TH; Delany ME
    Cytogenet Genome Res; 2011; 135(1):65-78. PubMed ID: 21822009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative lengthening of telomeres is a self-perpetuating process in ALT-associated PML bodies.
    Zhang JM; Genois MM; Ouyang J; Lan L; Zou L
    Mol Cell; 2021 Mar; 81(5):1027-1042.e4. PubMed ID: 33453166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1.
    Wu G; Jiang X; Lee WH; Chen PL
    Cancer Res; 2003 May; 63(10):2589-95. PubMed ID: 12750284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase IIIalpha is required for normal proliferation and telomere stability in alternative lengthening of telomeres.
    Temime-Smaali N; Guittat L; Wenner T; Bayart E; Douarre C; Gomez D; Giraud-Panis MJ; Londono-Vallejo A; Gilson E; Amor-Guéret M; Riou JF
    EMBO J; 2008 May; 27(10):1513-24. PubMed ID: 18418389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation.
    Chung I; Leonhardt H; Rippe K
    J Cell Sci; 2011 Nov; 124(Pt 21):3603-18. PubMed ID: 22045732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPF activates break-induced telomere synthesis.
    Guh CY; Shen HJ; Chen LW; Chiu PC; Liao IH; Lo CC; Chen Y; Hsieh YH; Chang TC; Yen CP; Chen YY; Chen TW; Chen LY; Wu CS; Egly JM; Chu HC
    Nat Commun; 2022 Oct; 13(1):5781. PubMed ID: 36184605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.